Please assess the completion status of the following clinical trial:

Trial Title: Treatments of Acquired Apraxia of Speech

Study Design Characteristics:
- Allocation: NON_RANDOMIZED
- Intervention Model: CROSSOVER
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: SINGLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Must have acquired apraxia of speech that occurred following a stroke or other brain injury.~* Must be at least 6 months post-onset of brain injury.~* May have aphasia.~Exclusion Criteria:~* History of drug or alcohol abuse.~* History of mental illness.~* Neurological condition other than that which resulted in apraxia of speech.

- Gender: ALL
- Minimum Age: 21 Years
- Maximum Age: 85 Years
- Healthy Volunteers: f

Study Arms:
- SPT-B then SPT-R (Type: EXPERIMENTAL): Participants first received Sound Production Treatment - Blocked (SPT-B) for 20 treatment sessions spanning approximately 7 weeks. After a washout period of 2 weeks, they then received Sound Production Treatment - Random (SPT-R) for 20 treatment sessions. Follow-up measures were conducted at 2, 6, and 10 weeks following the end of all treatment.
- SPT-R then SPT-B (Type: EXPERIMENTAL): Participants first received Sound Production Treatment - Random (SPT-R) for 20 treatment sessions spanning approximately 7 weeks. After a washout period of 2 weeks, they then received Sound Production Treatment - Blocked (SPT-B) for 20 treatment sessions. Follow-up measures were conducted at 2, 6, and 10 weeks following the end of all treatment.

Based on this trial design, predict the completion outcome and termination type (if applicable).